London, United Kingdom
February 17, 2026

It gives us huge pleasure to announce Resurrect Bio has made an initial close of over $8 million in our Series A financing round

We are on a mission to become the world's leading plant disease resistance company and this investment brings us one step closer 🌱💪

The round was led by Corteva Agriscience, alongside Calculus Capital, Pymwymic, UK Innovation & Science Seed Fund [UKI2S], SynBioVen and AgFunder. The team is excited to work with you on strengthening global food security and providing alternatives to chemical inputs

With this financing, we will ramp up production of our in-house crop protection traits and take our computational protein-protein interaction screening tool, FloraFold® AI, to the next level.

Thank you to all our investors, advisors, mentors, partners and, of course, our team throughout this process.

Website: https://www.resurrect.bio/

Published: February 20, 2026